tradmap

NVNO Earnings enVVeno Medical Corp

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$45 -$22 $0 2022 2023 2024 2025
EPS

Quarterly results

Diluted EPS (quarterly)
-$19 -$10 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS

Reported EPS history

1–17 of 17
Q2 20262026-06-30-11.182026-07-3010-Q
Q1 20262026-03-31-5.892026-05-0610-Q
FY 20252025-12-31-33.062026-03-2610-K
Q3 20252025-09-30-0.782025-10-3010-Q
Q2 20262025-06-30-19.272026-07-3010-Q
Q1 20262025-03-31-7.752026-05-0610-Q
FY 20252024-12-31-44.532026-03-2610-K
Q3 20252024-09-30-0.972025-10-3010-Q
Q2 20252024-06-30-0.622025-07-3110-Q
Q1 20252024-03-31-0.312025-04-3010-Q
FY 20242023-12-31-1.912025-02-2810-K
Q3 20242023-09-30-1.592024-10-3110-Q
Q2 20242023-06-30-1.152024-07-3110-Q
Q1 20242023-03-31-0.572024-05-0810-Q
FY 20232022-12-31-2.202024-02-2910-K
Q3 20232022-09-30-1.652023-10-2610-Q
Q2 20232022-06-30-1.102023-07-3110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.